Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Vesely

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
CASE (Philadelphia, Pa.)|October 6, 2025
Cor Triatriatum Sinister in a 34-Year-Old WomanMichael L Cheng, Alex Gyftopoulos, Justin Brilliant, et al.
The American Journal of Cardiology|October 23, 2008
Evidence for early right ventricular and septal mechanical activation (interventricular dyssynchrony) in pulmonary hypertensionDaniel J Schwartz, Willem J Kop, Myung H Park, et al.
American Heart Journal|April 25, 2007
A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failureStephen S Gottlieb, Willem J Kop, Sue A Thomas, et al.
JACC. Case Reports|March 11, 2024
Recurrent Stent Thrombosis Following Myocardial Infarction Associated With VITT-Like AntibodiesZulqarnain Khan, Imari Patel, Tiffany Gardner, et al.
The American Journal of Cardiology|March 1, 2008
Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiographyMark R Vesely, Shuying Li, Willem J Kop, et al.
The Annals of Thoracic Surgery|June 20, 2020
Development of a Reproducible Swine Model of Chronic Ischemic Mitral Regurgitation: Lessons LearnedChetan Pasrija, Rachael W Quinn, Hani Alkhatib, et al.
Innovations (Philadelphia, Pa.)|August 31, 2013
Robotically assisted hybrid coronary revascularization: does sequence of intervention matter?Mukta C Srivastava, Mark R Vesely, Jeffrey D Lee, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics ProgramAlan R Shuldiner, Kathleen Palmer, Ruth E Pakyz, et al.
Journal of the American Heart Association|February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical SettingsAmber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics|December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet TherapyPhilip E Empey, James M Stevenson, Sony Tuteja, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
CASE (Philadelphia, Pa.)|October 6, 2025
Cor Triatriatum Sinister in a 34-Year-Old WomanMichael L Cheng, Alex Gyftopoulos, Justin Brilliant, et al.
The American Journal of Cardiology|October 23, 2008
Evidence for early right ventricular and septal mechanical activation (interventricular dyssynchrony) in pulmonary hypertensionDaniel J Schwartz, Willem J Kop, Myung H Park, et al.
American Heart Journal|April 25, 2007
A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failureStephen S Gottlieb, Willem J Kop, Sue A Thomas, et al.
JACC. Case Reports|March 11, 2024
Recurrent Stent Thrombosis Following Myocardial Infarction Associated With VITT-Like AntibodiesZulqarnain Khan, Imari Patel, Tiffany Gardner, et al.
The American Journal of Cardiology|March 1, 2008
Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiographyMark R Vesely, Shuying Li, Willem J Kop, et al.
The Annals of Thoracic Surgery|June 20, 2020
Development of a Reproducible Swine Model of Chronic Ischemic Mitral Regurgitation: Lessons LearnedChetan Pasrija, Rachael W Quinn, Hani Alkhatib, et al.
Innovations (Philadelphia, Pa.)|August 31, 2013
Robotically assisted hybrid coronary revascularization: does sequence of intervention matter?Mukta C Srivastava, Mark R Vesely, Jeffrey D Lee, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics ProgramAlan R Shuldiner, Kathleen Palmer, Ruth E Pakyz, et al.
Journal of the American Heart Association|February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical SettingsAmber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics|December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet TherapyPhilip E Empey, James M Stevenson, Sony Tuteja, et al.
Pageof 3